ArticleArchives of general psychiatry2011
Ten-year trends in quality of care and spending for depression: 1996 through 2005.
Article in Archives of general psychiatry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial.Brain and behavior · 2017Trial
- Comparison of Risk of Stroke in Patients With and Without Depression: A Systematic Review and Meta-Analysis.Cureus · 2024Review
- More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation.Psychotherapy and psychosomatics · 2023Article
- Assessment of Outcome-Based Measures of Depression Care Quality in Veterans Health Administration Facilities.The journal of behavioral health services & research · 2023Article
- Medical service utilisation and direct medical cost of depression: a cross-sectional analysis of urban medical claims data from China.BMJ open · 2022Article
- Trends in Treatment and Spending for Patients Receiving Outpatient Treatment of Depression in the United States, 1998-2015.JAMA psychiatry · 2019Article
- Individual and neighborhood characteristics as predictors of depression symptom response.Health services research · 2019Article
- Depression may not be a risk factor for mortality in stroke patients with nonsurgical treatment: A retrospective case-controlled study.Medicine · 2019Article
- Pilot study of enhanced social support with automated telephone monitoring after psychiatric hospitalization for depression.Social psychiatry and psychiatric epidemiology · 2017Article
- The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness.Medical care · 2016Article
- Evaluating antidepressant treatment prior to adding second-line therapies among patients with treatment-resistant depression.International journal of clinical pharmacy · 2016Observational
- Preferences and Barriers to Care Following Psychiatric Hospitalization at Two Veterans Affairs Medical Centers: A Mixed Methods Study.The journal of behavioral health services & research · 2016Article
- National trends in second-generation antipsychotic augmentation for nonpsychotic depression.The Journal of clinical psychiatry · 2014Article
- The drugs don't work? antidepressants and the current and future pharmacological management of depression.Therapeutic advances in psychopharmacology · 2012Article
- Changes in Self-Reported Depressive Symptoms Among Adults in the United States From 2005 to 2016.Journal of the American Psychiatric Nurses AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
contextDuring the past decade, the introduction of generic versions of newer antidepressants and the release of Food and Drug Administration warnings regarding suicidality in children, adolescents, and young adults may have had an effect on cost and quality of depression treatment.
objectivesTo examine longitudinal trends in health service utilization, spending, and quality of care for depression.
designObservational trend study.
settingFlorida Medicaid enrollees, between July 1, 1996, and June 30, 2006. Patients Annual cohorts aged 18 to 64 years diagnosed as having depression.
main outcome measuresMental health care spending (adjusted for inflation and case mix), as well as its components, including inpatient, outpatient, and medication expenditures. Quality-of-care measures included medication adherence, psychotherapy, and follow-up visits.
resultsMental health care spending increased from a mean of $2802 per enrollee to $3610 during this period (29% increase). This increase occurred despite a mean decrease in inpatient spending from $641 per enrollee to $373 and was driven primarily by an increase in pharmacotherapy spending (up 110%), the bulk of which was due to spending on antipsychotics (949% increase). The percentage of enrollees with depression who were hospitalized decreased from 9.1% to 5.1%, and the percentage who received psychotherapy decreased from 56.6% to 37.5%. Antidepressant use increased from 80.6% to 86.8%, anxiety medication use was unchanged at 62.7% and 64.4%, and antipsychotic use increased from 25.9% to 41.9%. Changes in quality of care were mixed, with antidepressant use improving slightly, psychotherapy utilization fluctuating, and follow-up visits decreasing.
conclusionsDuring a 10-year period, spending for Medicaid enrollees with depression increased substantially, with minimal improvements in quality of care. Antipsychotic use contributed significantly to the increase in spending, while contributing little to traditional measures of quality of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.